No Data
No Data
Trending Industry Today: WUXI APPTEC Leads Losses In Biotechnology Stocks
Trending Industry Today: TIGERMED Leads Losses In CRO Stocks
Trending Industry Today: WUXI XDC Leads Losses In Biotechnology Stocks
Wuxi Bio (02269.HK) spent 49.765 million Hong Kong dollars on October 8 to buy back 2.53 million shares.
Gelonghui October 8th | wuxi bio (02269.HK) announced that on October 8th, it spent 49.765 million Hong Kong dollars to repurchase 2.53 million shares.
Trending Industry Today: TIGERMED Leads Losses In Biotechnology Stocks
[Brokerage Focus] China Post Securities expects the pharmaceutical sector to continue to rise uniformly, suggesting prioritizing the layout of various segmented sectors and leading companies in the first and second tiers during the general rise phase.
Golden Herald Financial News | China Post Securities stated that since the end of September, the pharmaceutical sector has been boosted by the national comprehensive incremental policy, solidly promoting the economy towards a higher-quality structure under the heavy bullish push, leading to a rapid rebound of the index by about 29%, reversing the continuous decline of nearly 4 years. Looking at the current PE (TTM), A-share pharmaceuticals are at 32 times, and Hong Kong stocks at 23 times. The previous continuous decline has already deviated from the fundamentals. The bank believes that the increase in market risk appetite will accelerate the sector's valuation repair. As of H1 2024, the institutions hold a 7.3% stake in the CSI SWS Health Care Index sector, which, although slightly lower than the end of 2023, still remains at a historically high level, indicating a general positive sentiment among institutions.